Intelligence Platform
Patents
Browse 774 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6331409
Methods and compositions for wound healing
expired patentUS 6326198
Methods and compositions for the ex vivo replication of stem cells, for the optimization o
expired patentUS 6303331
Vertebrate apoptosis gene: compositions and methods
expired patentUS 6303334
Nucleic acid encoding a transdominant negative retroviral integrase
expired patentUS 6299898
Methods and compositions for the treatment of wounds
expired patentUS 6297219
Site-specific instillation of cells or site-specific transformation of cells and kits ther
expired patentUS 6294169
Interleukin-1 beta converting enzyme like apoptotic protease-6
expired patentUS 6287537
Radioimmunotherapy of lymphoma using anti-CD20 antibodies
expired patentUS 6284242
Method for enhancing myoblast migration and invasion in the context of gene therapy
expired patentUS 6281256
Open pore biodegradable matrices
expired patentUS 6255519
Radioiodinated phospholipid ether analogs and methods of using the same
expired patentUS 6255336
Amino ceramide-like compounds and therapeutic methods of use
expired patentUS 6251362
Method of establishing the optimal radiation dose
expired patentUS 6238861
Neurofibromatosis gene
expired patentUS 6218372
Methods for treating restenosis with p21
expired patentUS 6214801
Imidazo[1,2-a]pyridine C-nucleosides as antiviral agents
expired patentUS 6207451
Mammalian muscle construct and method for producing same
expired patentUS 6203991
Inhibition of smooth muscle cell migration by heme oxygenase I
expired patentUS 6177272
Method for treating vascular proliferative diseases with p27 and fusions thereof
expired patentUS 6171855
Vectors
expired patentUS 6162641
Neuregulin response element and uses therefor
expired patentUS 6162432
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using
expired patentUS 6150164
Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
expired patentUS 6143719
Bradykinin analogs as selective thrombin inhibitors
expired